Successful use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease

Published: 12 March 2024| Version 1 | DOI: 10.17632/g7tz37rgsb.1
Contributor:
Mary Grace Hren

Description

Supplemental data describing patient demographics and characteristics from our dataset.

Files

Institutions

Icahn School of Medicine at Mount Sinai

Categories

Dermatology

Licence